Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative

Max Weinbrecht-Mischkewitz; Midhat Kamal; Farwa Asim; Francis Guillemin; Niti Goel; Marieke Voshaar; Annelies Boonen; Dorthe Bang Berthelsen; Karine Toupin-April; Maria A Lopez-Olivo; Victor S Sloan; Maarten Boers; C Allyson Jones; Irene van der Horst-Bruinsma; Aidan G Cashin; Saurab Sharma; Amye Leong; Rieke Alten; Beverley Shea; Lyn March; Peter Tugwell; Robin Christensen; Sabrina Mai Nielsen; Contextual Factors Working Group

doi:10.1016/j.semarthrit.2024.152370

Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative

Max Weinbrecht-Mischkewitz^*, Midhat Kamal, Farwa Asim, Francis Guillemin, Niti Goel, Marieke Voshaar, Annelies Boonen, Dorthe Bang Berthelsen, Karine Toupin-April, Maria A Lopez-Olivo, Victor S Sloan, Maarten Boers, C Allyson Jones, Irene van der Horst-Bruinsma, Aidan G Cashin, Saurab Sharma, Amye Leong, Rieke Alten, Beverley Shea, Lyn MarchPeter Tugwell, Robin Christensen, Sabrina Mai Nielsen, Contextual Factors Working Group

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

OBJECTIVES: To generate candidates for contextual factors (CFs) for each CF type (i.e., Effect Modifying Contextual Factors (EM-CFs), Outcome Influencing Contextual Factors (OI-CFs), and Measurement Affecting Contextual Factors (MA-CFs)) considered important within rheumatology. METHODS: We surveyed OMERACT working groups and conducted a Special Interest Group (SIG) session at the OMERACT 2023 meeting, where the results were reviewed, and additional CFs suggested. RESULTS: The working groups suggested 44, 49, and 21 generic EM-CFs, OI-CFs, and MA-CFs, respectively. SIG participants added 49, 44, and 55 factors, respectively. CONCLUSION: Candidate CFs were identified, next step is a consensus-based set of endorsed (important) CFs.

Original language	English
Article number	152370
Number of pages	7
Journal	Seminars in Arthritis and Rheumatism
Volume	65
DOIs	https://doi.org/10.1016/j.semarthrit.2024.152370
Publication status	Published - 10 Jan 2024

Keywords

Arthritis
Contextual factors
Effect modifiers
Measurement instruments
OMERACT
Prognostic factors
Rheumatology

Access to Document

10.1016/j.semarthrit.2024.152370Licence: CC BY

Cite this

Weinbrecht-Mischkewitz, M., Kamal, M., Asim, F., Guillemin, F., Goel, N., Voshaar, M., Boonen, A., Berthelsen, D. B., Toupin-April, K., Lopez-Olivo, M. A., Sloan, V. S., Boers, M., Jones, C. A., van der Horst-Bruinsma, I., Cashin, A. G., Sharma, S., Leong, A., Alten, R., Shea, B., ... Contextual Factors Working Group (2024). Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative. Seminars in Arthritis and Rheumatism, 65, Article 152370. https://doi.org/10.1016/j.semarthrit.2024.152370

@article{8643dbe648704ba2a6d2f80b28951541,

title = "Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative",

abstract = "OBJECTIVES: To generate candidates for contextual factors (CFs) for each CF type (i.e., Effect Modifying Contextual Factors (EM-CFs), Outcome Influencing Contextual Factors (OI-CFs), and Measurement Affecting Contextual Factors (MA-CFs)) considered important within rheumatology. METHODS: We surveyed OMERACT working groups and conducted a Special Interest Group (SIG) session at the OMERACT 2023 meeting, where the results were reviewed, and additional CFs suggested. RESULTS: The working groups suggested 44, 49, and 21 generic EM-CFs, OI-CFs, and MA-CFs, respectively. SIG participants added 49, 44, and 55 factors, respectively. CONCLUSION: Candidate CFs were identified, next step is a consensus-based set of endorsed (important) CFs.",

keywords = "Arthritis, Contextual factors, Effect modifiers, Measurement instruments, OMERACT, Prognostic factors, Rheumatology",

author = "Max Weinbrecht-Mischkewitz and Midhat Kamal and Farwa Asim and Francis Guillemin and Niti Goel and Marieke Voshaar and Annelies Boonen and Berthelsen, {Dorthe Bang} and Karine Toupin-April and Lopez-Olivo, {Maria A} and Sloan, {Victor S} and Maarten Boers and Jones, {C Allyson} and {van der Horst-Bruinsma}, Irene and Cashin, {Aidan G} and Saurab Sharma and Amye Leong and Rieke Alten and Beverley Shea and Lyn March and Peter Tugwell and Robin Christensen and Nielsen, {Sabrina Mai} and {Contextual Factors Working Group}",

year = "2024",

month = jan,

day = "10",

doi = "10.1016/j.semarthrit.2024.152370",

language = "English",

volume = "65",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W B Saunders Co-Elsevier Inc",

}

Weinbrecht-Mischkewitz, M, Kamal, M, Asim, F, Guillemin, F, Goel, N, Voshaar, M, Boonen, A, Berthelsen, DB, Toupin-April, K, Lopez-Olivo, MA, Sloan, VS, Boers, M, Jones, CA, van der Horst-Bruinsma, I, Cashin, AG, Sharma, S, Leong, A, Alten, R, Shea, B, March, L, Tugwell, P, Christensen, R, Nielsen, SM & Contextual Factors Working Group 2024, 'Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative', Seminars in Arthritis and Rheumatism, vol. 65, 152370. https://doi.org/10.1016/j.semarthrit.2024.152370

Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative. / Weinbrecht-Mischkewitz, Max; Kamal, Midhat; Asim, Farwa et al.
In: Seminars in Arthritis and Rheumatism, Vol. 65, 152370, 10.01.2024.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies

T2 - An OMERACT initiative

AU - Weinbrecht-Mischkewitz, Max

AU - Kamal, Midhat

AU - Asim, Farwa

AU - Guillemin, Francis

AU - Goel, Niti

AU - Voshaar, Marieke

AU - Boonen, Annelies

AU - Berthelsen, Dorthe Bang

AU - Toupin-April, Karine

AU - Lopez-Olivo, Maria A

AU - Sloan, Victor S

AU - Boers, Maarten

AU - Jones, C Allyson

AU - van der Horst-Bruinsma, Irene

AU - Cashin, Aidan G

AU - Sharma, Saurab

AU - Leong, Amye

AU - Alten, Rieke

AU - Shea, Beverley

AU - March, Lyn

AU - Tugwell, Peter

AU - Christensen, Robin

AU - Nielsen, Sabrina Mai

AU - Contextual Factors Working Group

PY - 2024/1/10

Y1 - 2024/1/10

N2 - OBJECTIVES: To generate candidates for contextual factors (CFs) for each CF type (i.e., Effect Modifying Contextual Factors (EM-CFs), Outcome Influencing Contextual Factors (OI-CFs), and Measurement Affecting Contextual Factors (MA-CFs)) considered important within rheumatology. METHODS: We surveyed OMERACT working groups and conducted a Special Interest Group (SIG) session at the OMERACT 2023 meeting, where the results were reviewed, and additional CFs suggested. RESULTS: The working groups suggested 44, 49, and 21 generic EM-CFs, OI-CFs, and MA-CFs, respectively. SIG participants added 49, 44, and 55 factors, respectively. CONCLUSION: Candidate CFs were identified, next step is a consensus-based set of endorsed (important) CFs.

AB - OBJECTIVES: To generate candidates for contextual factors (CFs) for each CF type (i.e., Effect Modifying Contextual Factors (EM-CFs), Outcome Influencing Contextual Factors (OI-CFs), and Measurement Affecting Contextual Factors (MA-CFs)) considered important within rheumatology. METHODS: We surveyed OMERACT working groups and conducted a Special Interest Group (SIG) session at the OMERACT 2023 meeting, where the results were reviewed, and additional CFs suggested. RESULTS: The working groups suggested 44, 49, and 21 generic EM-CFs, OI-CFs, and MA-CFs, respectively. SIG participants added 49, 44, and 55 factors, respectively. CONCLUSION: Candidate CFs were identified, next step is a consensus-based set of endorsed (important) CFs.

KW - Arthritis

KW - Contextual factors

KW - Effect modifiers

KW - Measurement instruments

KW - OMERACT

KW - Prognostic factors

KW - Rheumatology

U2 - 10.1016/j.semarthrit.2024.152370

DO - 10.1016/j.semarthrit.2024.152370

M3 - Article

SN - 0049-0172

VL - 65

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

M1 - 152370

ER -

Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative

Abstract

Keywords

Access to Document

Fingerprint

Cite this